Gene · 1847
Papers1,652
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,652
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The genomic landscape and clonal evolutionary trajectory of classical hairy cell leukemia. | Leukemia | 2023 | 36709352 | PubTator, text mining | PubMed |
| Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance. | Mol Syst Biol | 2023 | 36700386 | PubTator, text mining | PubMed |
| Peripheral Blood Gene Expression Profile of Infants with Atopic Dermatitis. | JID Innov | 2023 | 36699197 | PubTator, text mining | PubMed |
| Mono(2-ethylhexyl) phthalate induces transcriptomic changes in placental cells based on concentration, fetal sex, and trophoblast cell type. | Arch Toxicol | 2023 | 36695872 | PubTator, text mining | PubMed |
| KIBRA Gene Variant Is Associated with Ability in Chess and Science. | Genes (Basel) | 2023 | 36672945 | PubTator, text mining | PubMed |
| Impaired Intestinal Permeability of Tricellular Tight Junctions in Patients with Irritable Bowel Syndrome with Mixed Bowel Habits (IBS-M). | Cells | 2023 | 36672170 | PubTator, text mining | PubMed |
| Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable? | Annu Rev Pharmacol Toxicol | 2023 | 36662585 | PubTator, text mining | PubMed |
| Targeted therapy for head and neck cancer: signaling pathways and clinical studies. | Signal Transduct Target Ther | 2023 | 36646686 | PubTator, text mining | PubMed |
| Integrated DNA Methylation/RNA Profiling in Middle Temporal Gyrus of Alzheimer's Disease. | Cell Mol Neurobiol | 2023 | 36596913 | PubTator, text mining | PubMed |
| Identification of Genes Involved in EGF-induced Apoptosis Using CRISPR/Cas9 Knockout Screening: Implications for Novel Therapeutic Targets in EGFR-Overexpressing Cancers. | Cancer Res Treat | 2023 | 36596724 | PubTator, text mining | PubMed |
| Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL. | Blood Adv | 2023 | 36516085 | PubTator, text mining | PubMed |
| Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic. | Biochem Pharmacol | 2023 | 36481346 | PubTator, text mining | PubMed |
| Circ_0000471 suppresses the progression of ovarian cancer through mediating mir-135b-5p/dusp5 axis. | Am J Reprod Immunol | 2023 | 36369900 | PubTator, text mining | PubMed |
| Targeting RAS mutants in malignancies: successes, failures, and reasons for hope. | Cancer Commun (Lond) | 2023 | 36316602 | PubTator, text mining | PubMed |
| Evaluation of cellular response to Clostridium difficile toxin-A: a network analysis. | Gastroenterol Hepatol Bed Bench | 2022 | 36762215 | PubTator, text mining | PubMed |
| Comparative analysis of thoracic and abdominal aortic aneurysms across the segment and species at the single-cell level. | Front Pharmacol | 2022 | 36703732 | PubTator, text mining | PubMed |
| YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity. | Front Pharmacol | 2022 | 36686648 | PubTator, text mining | PubMed |
| Transcriptomic data analysis coupled with copy number aberrations reveals a blood-based 17-gene signature for diagnosis and prognosis of patients with colorectal cancer. | Front Genet | 2022 | 36685857 | PubTator, text mining | PubMed |
| Non-Coding RNAs in the Regulation of Hippocampal Neurogenesis and Potential Treatment Targets for Related Disorders. | Biomolecules | 2022 | 36671403 | PubTator, text mining | PubMed |
| Characteristics and transcriptomic analysis of scar tissues on the inner uterine cavity wall in patients with intrauterine adhesions. | Front Physiol | 2022 | 36620214 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1847/papers?page=12